Skip to main content

Table 4 Mean Neutrophil Lymphocyte ratio of esophageal cancer patients diagnosed at. AUBMC between 1995 and 2019

From: Esophageal cancer: a twenty-four-year experience at a tertiary care center with an evaluation of the prognostic significance of the neutrophil-lymphocyte ratio

Factor

Variable

NLRa

P-value

Tumor type

Squamous cell carcinoma (n = 33)

5.9 (9.2)

0.420

Adenocarcinoma (n = 37)

4.5 (3.4)

Tumor stage

I (n = 4)

9.0 (14.2)

0.637

II (n = 8)

3.7 (2.5)

III (n = 37)

4.8 (7.5)

IV (n = 10)

4.0 (3.1)

Tumor grade

Poorly differentiated (n = 15)

4.8 (4.4)

0.530

Moderately differentiated (n = 40)

6.2 (8.5)

Well differentiated (n = 6)

2.1 (0.4)

  1. aValues are produced as means (±SD)
  2. Mean neutrophil lymphocyte ratio: 5.2 (6.8), n = 70 patients